JP Stock MarketDetailed Quotes

Cyfuse Biomedical KK (4892)

Watchlist
  • 530
  • -7-1.30%
20min DelayMarket Closed Jun 15 15:30 JST
5.35BMarket Cap-6.11P/E (Static)

Cyfuse Biomedical KK (4892) Key Financial Indicators

4892 Earnings per Share (EPS)

According to the latest financial report of Cyfuse Biomedical KK, the latest earnings per share (TTM) for the company is -22.56. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

Loading...

4892 Free Cash Flow (FCF)

Interested in knowing about Cyfuse Biomedical KK's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Loading...

4892 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cyfuse Biomedical KK shows that the company's current ratio is 4.55, indicating healthy liquidity.

Currency: JPY

Quarterly

Loading...

4892 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cyfuse Biomedical KK, the quick ratio is 4.33, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

Loading...

4892 Return on Equity (ROE)

Want to learn more about the financial health of Cyfuse Biomedical KK? The latest ROE figure is -8.14%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

Loading...

4892 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cyfuse Biomedical KK, the total asset return on investment (ROA) is -5.36%.

Currency: JPY

Quarterly

Loading...

4892 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cyfuse Biomedical KK's latest financial report to see how their gross margin is doing - currently at 70.47%.

Currency: JPY

Quarterly

Loading...

4892 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cyfuse Biomedical KK, the net profit margin is -787.05%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Loading...

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The more than three-month-long U.S.-Iran war has finally come to an end! Pakistani Prime Minister Shehbaz announced on Sunday that the Unite Show More